ID
28157
Beskrivning
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Concomitant medications - Repeating form (Scheduled visits)
Nyckelord
Versioner (5)
- 2017-09-24 2017-09-24 -
- 2017-10-04 2017-10-04 -
- 2017-10-04 2017-10-04 -
- 2017-10-23 2017-10-23 -
- 2017-12-22 2017-12-22 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
22 december 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Concomitant medications Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
Concomitant medications Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
Similar models
Concomitant medications Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
C0871468 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C2347852 (UMLS CUI [1,2])